Myelodysplastic–myeloproliferative diseases

From WikiMD's WELLNESSPEDIA

Group of diseases

Myelodysplastic–myeloproliferative diseases





Specialty Hematology
Symptoms Fatigue, anemia, splenomegaly, fever
Complications Acute myeloid leukemia, bone marrow failure



Types Chronic myelomonocytic leukemia, Atypical chronic myeloid leukemia, Juvenile myelomonocytic leukemia



Diagnosis Blood test, bone marrow biopsy



Treatment Chemotherapy, stem cell transplant






Myelodysplastic–myeloproliferative diseases (MDS/MPN) are a group of hematologic disorders characterized by features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). These diseases are marked by the abnormal growth and development of blood cells in the bone marrow, leading to a combination of cytopenias and cytoses.

Classification[edit]

Myelodysplastic–myeloproliferative diseases are classified into several subtypes, including:

Symptoms[edit]

Common symptoms of MDS/MPN include:

Complications[edit]

Patients with MDS/MPN are at risk for developing:

Diagnosis[edit]

Diagnosis of MDS/MPN typically involves:

  • Blood tests to evaluate blood cell counts and morphology
  • Bone marrow biopsy to assess the cellularity and presence of dysplastic or proliferative features

Treatment[edit]

Treatment options for MDS/MPN may include:

Related Pages[edit]

Stub icon

This hematology article is a stub. You can help WikiMD by expanding the page.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Myelodysplastic–myeloproliferative_diseases&oldid=5898852"